Price Alert

Cyclerion Therapeutics In... (CYCN)

NASDAQ: CYCN · Real-Time Price · USD

2.43

0.10 (4.29%)

At close: Aug 15, 2025, 1:24 PM

4.29% (1D)

Bid	2.38
Market Cap	8.11M
Revenue (ttm)	2.17M
Net Income (ttm)	-1.95M
EPS (ttm)	-0.69
PE Ratio (ttm)	-3.52
Forward PE	-0.11
Analyst	n/a

Ask	2.43
Volume	25,838
Avg. Volume (20D)	36,696
Open	2.34
Previous Close	2.33
Day's Range	2.30 - 2.44
52-Week Range	1.27 - 9.47
Beta	1.68

About CYCN

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol CYCN

Website n/a

Full Company Profile

Why Price Moved

1 week ago

+3.58%

Cyclerion Therapeutics shares are trading lower. T... Unlock content with Pro Subscription

News

3 years ago · zacks.com

Cyclerion Therapeutics, Inc. (CYCN) Reports Q2 Loss, Misses Revenue Estimates

Cyclerion Therapeutics, Inc. (CYCN) delivered earnings and revenue surprises of 8.82% and 56.90%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the st...

3 years ago · benzinga.com

Cyclerion Neurology Candidate Shows Encouraging Action In Preclinical Studies

Cyclerion Therapeutics Inc's (NASDAQ: CYCN) preclinical studies demonstrated its lead soluble guanylate cyclase (sGC) stimulator, CY6463, improved cellular energetics and reduced inflammation in precl...